Published in FEBS J on December 29, 2009
Regulation of aggression by obesity-linked genes TfAP-2 and Twz through octopamine signaling in Drosophila. Genetics (2013) 0.89
Deciphering gene expression program of MAP3K1 in mouse eyelid morphogenesis. Dev Biol (2012) 0.85
Development of a model system to analyze chondrogenic differentiation of mesenchymal stem cells. Int J Clin Exp Pathol (2013) 0.83
Inflammatory gene regulatory networks in amnion cells following cytokine stimulation: translational systems approach to modeling human parturition. PLoS One (2011) 0.81
Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma. Epigenetics (2014) 0.81
Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts. Int J Clin Exp Pathol (2015) 0.78
Low Molecular Weight Fraction of Commercial Human Serum Albumin Induces Morphologic and Transcriptional Changes of Bone Marrow-Derived Mesenchymal Stem Cells. Stem Cells Transl Med (2015) 0.77
Transcriptional control of chondrocyte specification and differentiation. Semin Cell Dev Biol (2016) 0.76
The AP-2 Transcription Factor APTF-2 Is Required for Neuroblast and Epidermal Morphogenesis in Caenorhabditis elegans Embryogenesis. PLoS Genet (2016) 0.75
Genes regulated by potassium channel tetramerization domain containing 15 (Kctd15) in the developing neural crest. Int J Dev Biol (2016) 0.75
Epigenetic programming of Dnmt3a mediated by AP2α is required for granting preadipocyte the ability to differentiate. Cell Death Dis (2016) 0.75
A Functional Variant Associated with Atrial Fibrillation Regulates PITX2c Expression through TFAP2a. Am J Hum Genet (2016) 0.75
Retracted Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts. Int J Clin Exp Pathol (2015) 0.75
A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease. Gastroenterology (2003) 2.40
miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol (2009) 2.06
Efficient transfection method for primary cells. Tissue Eng (2002) 1.74
Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma. J Exp Med (2009) 1.59
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol (2009) 1.54
Slit3 inhibits activator protein 1-mediated migration of malignant melanoma cells. Int J Mol Med (2011) 1.49
Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene (2005) 1.41
Reduced expression of CYLD in human colon and hepatocellular carcinomas. Carcinogenesis (2006) 1.29
Snail-regulated genes in malignant melanoma. Melanoma Res (2005) 1.17
Upregulation of HMG1 leads to melanoma inhibitory activity expression in malignant melanoma cells and contributes to their malignancy phenotype. Mol Cell Biol (2003) 1.17
Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncol Rep (2006) 1.14
A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts. PLoS One (2012) 1.07
H-cadherin expression reduces invasion of malignant melanoma. Pigment Cell Melanoma Res (2009) 1.04
Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA). Am J Pathol (2011) 1.04
Inhibition of melanoma inhibitory activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes. Pigment Cell Res (2005) 1.04
Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells. Melanoma Res (2007) 1.03
Functional implication of Netrin expression in malignant melanoma. Cell Oncol (2009) 1.02
Direct and tumor microenvironment mediated influences of 5'-deoxy-5'-(methylthio)adenosine on tumor progression of malignant melanoma. J Cell Biochem (2009) 0.99
Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma. Cancer Biomark (2007) 0.98
CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma. Carcinogenesis (2013) 0.95
Novel bioimaging techniques of metals by laser ablation inductively coupled plasma mass spectrometry for diagnosis of fibrotic and cirrhotic liver disorders. PLoS One (2013) 0.95
Reduced expression of TANGO in colon and hepatocellular carcinomas. Oncol Rep (2007) 0.93
Fibrosing connective tissue disorders of the skin: molecular similarities and distinctions. J Dermatol Sci (2013) 0.93
Loss of maspin expression contributes to a more invasive potential in malignant melanoma. Pigment Cell Res (2007) 0.91
Increased KGF expression promotes fibroblast activation in a double paracrine manner resulting in cutaneous fibrosis. J Invest Dermatol (2012) 0.91
Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C. Liver Int (2004) 0.91
Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma. Exp Dermatol (2010) 0.91
Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different. Virchows Arch (2014) 0.91
Functional role of MIA in melanocytes and early development of melanoma. Oncogene (2004) 0.90
Induction of Raf kinase inhibitor protein contributes to macrophage differentiation. Biochem Biophys Res Commun (2006) 0.90
Regulation of polyamine synthesis in human hepatocytes by hepatotrophic factor augmenter of liver regeneration. Biochem Biophys Res Commun (2006) 0.89
RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Mol Cancer Ther (2005) 0.89
Sox9 modulates cell survival and adipogenic differentiation of multipotent adult rat mesenchymal stem cells. J Cell Sci (2013) 0.89
TANGO is a tumor suppressor of malignant melanoma. Int J Cancer (2006) 0.88
Expression of integrin alpha10 is induced in malignant melanoma. Cell Oncol (2007) 0.88
BRN2 is a transcriptional repressor of CDH13 (T-cadherin) in melanoma cells. Lab Invest (2012) 0.88
miR(acle)s - new players in the regulation of known suspects. Pigment Cell Melanoma Res (2009) 0.88
The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes. FEBS J (2009) 0.86
Slit3 inhibits Robo3-induced invasion of synovial fibroblasts in rheumatoid arthritis. Arthritis Res Ther (2010) 0.85
Regulation of integrin alpha10 expression in chondrocytes by the transcription factors AP-2epsilon and Ets-1. Biochem Biophys Res Commun (2006) 0.85
Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma. Exp Mol Pathol (2013) 0.84
Quantitative analysis of 5'-deoxy-5'-methylthioadenosine in melanoma cells by liquid chromatography-stable isotope ratio tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.84
Loss of E-cadherin-mediated cell-cell contacts activates a novel mechanism for up-regulation of the proto-oncogene c-Jun. Mol Biol Cell (2009) 0.84
BAP1 germline mutation in two first grade family members with uveal melanoma. Br J Ophthalmol (2013) 0.84
Nucleosome remodeler SNF2L suppresses cell proliferation and migration and attenuates Wnt signaling. Mol Cell Biol (2012) 0.83
Tissue microarray analysis of methylthioadenosine phosphorylase protein expression in melanocytic skin tumors. Arch Dermatol (2006) 0.83
Loss of nephronectin promotes tumor progression in malignant melanoma. Cancer Sci (2008) 0.83
Annexin A5 is involved in migration and invasion of oral carcinoma. Cell Cycle (2009) 0.82
Quantification of intermediates of the methionine and polyamine metabolism by liquid chromatography-tandem mass spectrometry in cultured tumor cells and liver biopsies. J Chromatogr A (2010) 0.82
Loss of full length CtBP1 expression enhances the invasive potential of human melanoma. BMC Cancer (2009) 0.82
Depletion of optineurin in RGC-5 cells derived from retinal neurons causes apoptosis and reduces the secretion of neurotrophins. Exp Eye Res (2011) 0.81
Meeting report from the 2011 International Melanoma Congress, Tampa, Florida. Pigment Cell Melanoma Res (2011) 0.81
Fragments of SLIT3 inhibit cellular migration. Int J Mol Med (2012) 0.80
Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells. Cancer Cell Int (2005) 0.80
WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis. EMBO Mol Med (2012) 0.80
Hypoferraemia during the early inflammatory response is dependent on tumour necrosis factor activity in a murine model of protracted peritonitis. Mol Med Rep (2012) 0.79
Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression. Cancer Res (2002) 0.79
Ultraviolet radiation induces release of MIA: a new mechanism for UVR-induced progression of melanoma. Int J Oncol (2004) 0.78
N-cadherin promoter polymorphisms and risk of osteoarthritis. FASEB J (2013) 0.77
The transcription factor activating enhancer-binding protein epsilon (AP-2ε) regulates the core promoter of type II collagen (COL2A1). FEBS J (2013) 0.76
In vitro behavior of a porous TiO2/perlite composite and its surface modification with fibronectin. Biomaterials (2005) 0.75
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations. Pigment Cell Melanoma Res (2014) 0.75
Correlation of a novel matrix protein with the degree of cartilage degradation. Rheumatol Int (2002) 0.75